drugset / Trial / NCT00446563

Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

NCT00446563

Phase 3 Completed 90 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of amlodipine plus valsartan in patients with hypertension and left ventricular hypertrophy

Timeline

Start
2007-03
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg Oral
Subject Amlodipine Other / unclassified 10 mg Oral
Comparator Hydrochlorothiazide Unknown 12.5 mg Oral
Comparator Hydrochlorothiazide Unknown 25 mg Oral
Comparator Losartan Other / unclassified 100 mg Oral
Subject Valsartan Small molecule 160 mg Oral